1.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CWRU-010224M, NCI-G02-2125, LILLY-H3E-MC-JMES, LILLY-LILY-1201, NCT00049426
|
|
2.
|
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-91173, NCI-V92-0026
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAM201, NCT00291785
|
|
4.
|
Phase: Phase II
Type: Prevention
Status: Closed
Age: 21 and over
Sponsor: NCI
Protocol IDs: E-8292, NCI-P95-0066, NCT00002650
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TULA-T064031, USO-01103, NCT00033722
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 6 months to 65 years
Sponsor:
Protocol IDs: EUC-47491, NCI-V92-0171
|
|
7.
|
Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: ONCO-021-98S, NCT00018551
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: HOG GU03-67, NCT00216099
|
|
9.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9732, H3E-MC-S077, NCT00330915
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PROPEL, PDX-008, NCT00364923
|
|
11.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MCV-MCC-9408-2B, NCI-T94-0121O, T94-0121
|
|
12.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: NCI
Protocol IDs: LAC-USC-0C941, NCI-T94-0142H, T94-0142
|
|
13.
|
Phase: Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0005068, TULA-T3004, NCI-G01-2017, NCT00024310
|
|
14.
|
Phase: Phase I
Type: Prevention
Status: Closed
Age: 40 to 72
Sponsor: NCI
Protocol IDs: RUH-PHO-0514-0404, RPCI-EPR-20703, AECM-0401022E, NEMCH-6060, NCT00096330
|
|
15.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 to 72
Sponsor: NCI
Protocol IDs: RUH-PHO-0514-0306, PHO-0514-0306, NCT00611000
|
|
16.
|
Phase: No phase specified
Type: Prevention
Status: Closed
Age: 21 to 80
Sponsor: NCI
Protocol IDs: DMS-CPHS-10293, NCI-P95-0063
|
|
17.
|
Phase: No phase specified
Type: Prevention
Status: Closed
Age: 75 and under
Sponsor: Other
Protocol IDs: QMC-UKCAP, EU-20045, NCT00033319
|
|
18.
|
Phase: No phase specified
Type: Prevention
Status: Closed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-8745, NCI-P89-0007
|
|
19.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: Under 75
Sponsor: NCI
Protocol IDs: BWH-1999-P-001674/10, 1999-P-001674/10, BWH-94-06819, NCT00512850
|
